NIDA Director outlines potential risks to people who smoke and use drugs during COVID-19 pandemic
April 8, 2020
The precarious intersection of the COVID-19 national health emergency and the concurrent epidemic of drug overdose deaths is outlined in the Annals of Internal Medicine this week by Dr. Nora D. Volkow, director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. Dr. Volkow discusses how the serious health risks of COVID-19 pose unique challenges to people who smoke or vape, are already struggling with substance use disorders (SUD), or are in recovery from addiction.

—
Facilitation
•
Data-Informed Practice
•
Metrics to Guide Community-Level Prevention